Jennifer Sheng
Novartis' Jennifer Sheng on Solubility Modelling & the Future of Solubilisation
December 10 by Andrea CharlesPoor solubility is an obvious barrier to advancing potentially efficacious drug candidates. In this interview Jennifer Sheng, Fellow at Novartis, discusses the most efficient approaches for...